0001669191-22-000553.txt : 20220511
0001669191-22-000553.hdr.sgml : 20220511
20220511152431
ACCESSION NUMBER: 0001669191-22-000553
CONFORMED SUBMISSION TYPE: C-U
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20220511
DATE AS OF CHANGE: 20220511
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioverge, Inc.
CENTRAL INDEX KEY: 0001828649
IRS NUMBER: 822592905
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: C-U
SEC ACT: 1933 Act
SEC FILE NUMBER: 020-27997
FILM NUMBER: 22913376
BUSINESS ADDRESS:
STREET 1: 237 KEARNY STREET #9171
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 8664151001
MAIL ADDRESS:
STREET 1: 237 KEARNY STREET
STREET 2: STE. 9171
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
C-U
1
primary_doc.xml
C-U
0001828649
XXXXXXXX
020-27997
LIVE
false
true
false
End of offering. Issuer closed its offering with estimated gross proceeds of $744,806. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption.
Bioverge, Inc.
Corporation
DE
08-17-2017
237 Kearny Street
Ste. 9171
San Francisco
CA
94108
https://bioverge.com/
N
NetCapital Funding Portal Inc.
0001669191
007-00035
283596
Up to 4.9% of amount raised for a successful offering
None.
Common Stock
5848
1.71000
We utilized three valuation methodologies: discounted cash flow, sum -of-the-parts, and comparable company analysis.
10000.08
Y
First-come, first-served basis
1069998.30
03-01-2022
2
975622.00
544624.00
570343.00
266383.00
7034.00
4997.00
123702.00
123702.00
1363520.00
588520.00
68795.00
24047.00
0.00
0.00
0.00
0.00
-432913.00
-161357.00
AL
AK
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
ME
MD
MA
MI
MN
MS
MO
MT
NE
NV
NH
NJ
NM
NY
NC
ND
OH
OK
OR
PA
RI
SC
SD
TN
TX
UT
VT
VA
WA
WV
WI
WY
B5
GU
1V
PR
VI
Bioverge, Inc.
Neil Littman
Principal Executive Officer
Neil Littman
Principal Executive Officer
05-11-2022
Neil Littman
Principal Financial Officer
05-11-2022
Neil Littman
Principal Accounting Officer
05-11-2022
Neil Littman
Board Member
05-11-2022